Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-016949
Filing Date
2016-04-28
Accepted
2016-04-28 16:02:33
Documents
39
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aldr-10q_20160331.htm 10-Q 1324276
2 EX-31.1 aldr-ex311_6.htm EX-31.1 15515
3 EX-31.2 aldr-ex312_8.htm EX-31.2 15512
4 EX-32.1 aldr-ex321_7.htm EX-32.1 8666
  Complete submission text file 0001564590-16-016949.txt   3610953

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldr-20160331.xml EX-101.INS 731159
6 XBRL TAXONOMY EXTENSION SCHEMA aldr-20160331.xsd EX-101.SCH 19374
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldr-20160331_cal.xml EX-101.CAL 31531
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldr-20160331_def.xml EX-101.DEF 39146
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldr-20160331_lab.xml EX-101.LAB 149840
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldr-20160331_pre.xml EX-101.PRE 113771
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Filer) CIK: 0001423824 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36431 | Film No.: 161599955
SIC: 2834 Pharmaceutical Preparations